Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Calidi Biotherapeutics is a clinical-stage immuno-oncology company developing proprietary allogeneic stem cell and enveloped virus platforms to deliver oncolytic viruses for cancer treatment. Its product candidates aim to enhance viral delivery, protect against immune neutralization, and modify tumor microenvironments. Focused on solid tumors and brain cancers, Calidi leverages off-the-shelf cell therapies to improve efficacy and safety in cancer immunotherapy.
This description was generated via AI from an annual report. Updated about 1 year ago.